Home
NewsNewsAksigen IVF has launched an innovative Immersive IVF Knowledge Centre in Mumbai, dedicated to advancing fertility education by demystifying complex IVF science and empowering patients to make informed, confident decisions about their family planning journey.
Aksigen IVF has launched India’s first Immersive IVF Knowledge Centre with the opening of the Bharat Daftary Knowledge Centre in Andheri East, Mumbai. The initiative is designed to address gaps in fertility awareness and improve how patients understand and navigate IVF treatment.
As IVF adoption increases across India, treatment decisions often involve complex medical information and emotional stress. Despite this, structured patient education has remained limited. The new Immersive IVF Knowledge Centre aims to bridge that gap by offering clear, science-backed explanations in a private and supportive setting.
Visitors explore the centre as a series of interconnected zones, engaging with bespoke installations and digital experiences. Led by Aksigen’s patient care experts, they discover how reproductive science works, understand common fertility conditions and are guided through IVF treatment journeys. Content is expertly curated to be reassuringly accurate, easy to understand and highly respectful of patient privacy and dignity.
Through a balance of immersive technologies and human-centred design, the centre unpicks fears around IVF and replaces misconceptions with understanding and confidence to make informed choices about their care.
Expressing his optimism on the launch, Dr. Gautam Daftary, Founder, Chairman and Managing Director of Aksigen IVF, stated, “The Bharat Daftary Knowledge Centre reflects our deep commitment to putting patients first. Fertility journeys can be emotionally and medically complex, and this centre has been created to simplify science, address fears, and empower individuals with the right information to make confident, informed choices.”
Highlighting the clinical relevance of the initiative, Dr. Shirish Daftary, ex Dean, Nowrosjee Wadia Maternity Hospital and Member, Scientific Advisory Board, Aksigen IVF said, “In fertility care, informed patients are better prepared patients. This Knowledge Centre allows us to explain complex medical concepts in a clear, visual, and reassuring manner, helping patients understand their condition, treatment options, and what to expect from their IVF journey. It enhances transparency and strengthens trust and enables more meaningful doctor–patient conversations.”
The Bharat Daftary Knowledge Centre comprises an Aksigen Legacy Zone detailing our history in reproductive medicine, an Immersive Education Zone with interactive digital content and curated storytelling experiences, as well as a Personalised Science Zone visually depicting patient journeys for specific fertility conditions. We’ve also enabled a 360-degree visual reproduction of the IVF journey for people to experience the process step-by-step using virtual reality.
Incorporating education into fertility treatment plans helps demystify the experience, minimises stress and fosters greater doctor–patient relationships. Launching the Knowledge Centre is part of our ongoing commitment to elevating transparency, evidence-led patient care and empowered choice as India’s fertility industry advances.
Wisconsin lawmakers from both parties are proposing bills to reduce IVF treatment costs. Republicans suggest a $5,000 tax credit for expenses, while Democrats want mandatory insurance coverage. With IVF cycles costing $20,000-$30,000 and 170,000 residents facing infertility, both parties seek affordable solutions through different approaches.
The AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
Alife Health secured CE Mark approval for its AI-powered embryo selection tool, Embryo Predict, under EU MDR, expanding its fertility technology presence across Europe.
Simbryo Technologies introduces the Simbryo FX personalized assay, a diagnostic test that measures endometrial fertility to predict embryo implantation success and improve IVF outcomes with more than 90% specificity.
South Korean couples travel abroad for gender-selective IVF procedures, spending dollars in Thailand and Cyprus due to domestic legal restrictions on choosing a baby's sex.
As more families pursue fertility treatments, IVF CRYO urges greater transparency and safety in better Safe Embryos and Eggs Shipping across the U.S.
China sees a rise in advanced maternal age In Vitro Fertilization, driven by BaseCare Medical’s AI undisturbed culture system that improves embryo quality and clinical pregnancy rates, especially with PGT. Localized AI-assisted solutions position BaseCare as a leader in smart, precision reproduction technology for older IVF patients.
